STADA Group

Trust in conventional medicine on the rise despite decreasing satisfaction 📈 Our #STADAHealthReport2024 shows that while satisfaction with the healthcare system is declining, trust in conventional medicine is increasing. In 2024, 69% of Europeans trust conventional medicine completely or mostly, up from 62% in 2022. Personal experiences play a significant role in building this trust. Many people believe their doctors and pharmacists know what's best for them, have experienced the positive effects of conventional treatments, and appreciate the decades of research and rigorous methodology behind it. For more insights and a detailed analysis, explore the STADA Health Report 2024: https://lnkd.in/eV75VmpF #STADAHealthReport #ConventionalMedicine #Healthcare #Report 

Inspiring Progress at STADA 📍 Spain! In 2023, STADA made remarkable strides in self-managing customer business documentation, such as e-invoices, duplicates, and the 347 forms, resulting in savings of over 50,000 EUR. This impressive figure is expected to be surpassed in 2024. E-invoicing alone led to a 16% reduction in paper invoices, significantly contributing to our sustainability commitment. Moreover, our beloved probiotic CHC brand, Lactoflora, began incorporating e-leaflets in all its packs, eliminating the need for paper versions. In just 12 months, over 160,000 Lactoflora packs were released with e-leaflets, saving 480 kg of paper and 7,000 EUR in costs. Additionally, 1,700 patients in Spain downloaded a Lactoflora e-leaflet, embracing this eco-friendly innovation. These efforts not only showcase our dedication to environmental sustainability but also highlight our commitment to efficiency and innovation. Together, we're making a significant difference! Read more about Sustainability at STADA: https://lnkd.in/eB7scevz #ItComesNaturallyToUs #TakingResponsibility #Sustainability #ESG STADA España

STADA is pleased to share a pivotal moment along our purpose: Caring for People’s Health as a Trusted Partner.   A few days ago, our new immunology biosimilar was prescribed to a patient with Crohn’s disease in the Czech Republic – this is the first prescription and use of an ustekinumab biosimilar treatment in Europe overall. This is a key milestone for patients and our company.   STADA was the first company to obtain a marketing authorization in Europe for an ustekinumab biosimilar*. We look forward to making this treatment option available to many more patients across Europe in the coming weeks and months. Having launched our first biosimilar in 2008, we have extensive experience to draw upon as we now introduced our seventh. We are proud to be leading the way in delivering transformative healthcare solutions to patients across Europe!   #STADA #HealthcareInnovation #Biosimilars #PatientCare #CaringForPeoplesHealth #HealthcareAccessibility *Disclaimer: Indicated for Crohn’s disease, psoriasis, and psoriatic arthritis – but not for ulcerative colitis, since the originator still has exclusivity for this indication.

Growth Mindset is fundamental to STADA's culture and success. However, whilst it is often talked about, bringing it to life in a company is not so easy. To see how we concretely understand 'Growth Mindset' at STADA Group, we recently asked the participants of the #GetGrowing program in Madrid 'What is a growth mindset?' What does it mean to you? Share Below ⬇ #GrowthMindsetter #OneSTADA #CultureDrivesPerformance #GrowthCulture

Heartwarming Impact from STADA 📍 Vietnam! We are immensely proud to share that STADA’s affiliate in Vietnam has been actively supporting a heartfelt initiative led by our internal Youth Union. In collaboration with the local City Youth Union and other Youth Unions from the health sector, such as provincial hospitals, we aimed to improve access to essential medicines in underserved, rural areas. This meaningful initiative included providing health checks and medicines to local communities, making a real difference in the lives of many. Throughout 2023, STADA supported five such activities, delivering over 500 medical units and treating more than 500 individuals. It’s incredible to see how our collective efforts are bringing hope and health to those who need it most. Read more about Sustainability at STADA: https://lnkd.in/eB7scevz #ItComesNaturallyToUs #TakingResponsibility #Sustainability #ESG PYMEPHARCO-STADA AG

Satisfaction with the Healthcare System drops to 56% in 2024 Our 2024 Health Report reveals a significant and concerning trend: satisfaction with the healthcare system has been declining for the fourth consecutive year. In 2020, satisfaction was at 74%, but by 2024, it has plummeted to just 56%. This steady decline highlights several critical issues: 👨⚕️Difficulties in getting appointments 🚑Inadequate care ⚕️Mistrust of decision-makers in the healthcare system The STADA Health Report not only explores these issues but also delves into their underlying causes and proposes actionable solutions. To understand the current state of the healthcare system explore the detailed insights here: https://lnkd.in/ehwrQjGe #STADAHealthReport2024 #HealthcareSystem #PatientSatisfaction #HealthcareSolutions #HealthInsights

Explore STADA EXPO – a multimedia exhibition! Through an interactive and sustainable prism, STADA Expo shows in an educational and innovative way combines science, technology and the people behind the whole process. At STADA EXPO, we invite you to delve into the essence of sustainable development through an immersive journey like no other. Designed to educate and inspire, this unique experience unfolds across four repurposed containers equipped with cutting-edge technology. From virtual reality glasses to interactive displays highlighting ESG principles, each step of the journey encourages visitors to reconsider everyday actions for a profound global impact. Beginning with our rich history and steadfast focus on preventive healthcare, STADA EXPO guides you through the intricate processes of our Technical Operations. Learn firsthand about our production cycle, from raw materials entering our facilities to finished products reaching our customers worldwide. Along the way, meet the diverse and dedicated individuals who embody STADA’s global family, representing 87 nations and a wealth of expertise. The experience culminates in a deep dive into our Environmental, Social, and Governance (ESG) initiatives, underscored by our commitment to sustainable business practices. Discover how STADA Group champions health, community, and environmental stewardship, aligning with the Sustainable Development Goals (SDGs) to shape a brighter future for generations to come. Read more about Sustainability at STADA: https://lnkd.in/eB7scevz #ItComesNaturallyToUs #TakingResponsibility #Sustainability #ESG

This year's Health Report is bigger and more comprehensive than ever, covering 23 countries with insights from 46,000 individuals. We’ve taken a step further by not only highlighting issues but also exploring the reasons behind them and proposing solutions. Our 2024 report delves into critical topics like Ageing, Mental Health, Self-care, or the impact of Digitalisation & AI. We also examine satisfaction with the healthcare system, providing a detailed analysis of both physical and mental health across Europe. The findings will be presented and analyzed over the coming weeks. For more information, visit our website: https://lnkd.in/eV75VmpF #STADAHealthReport #HealthReport2024 #HealthcareSystem #STADA

We’re thrilled to share that, in addition to our extensive range of generic and consumer healthcare products, STADA is dedicated to developing and providing specialty medicines for chronic, life-changing, and rare health conditions. Our mission is to offer high-quality treatments that not only support public healthcare systems but also truly make a difference in people’s lives. By continually enhancing our product portfolio and collaborating closely with our employees, stakeholders, and local communities, STADA is passionately committed to making the world a healthier and stronger place. Read more about Sustainability at STADA: https://lnkd.in/eB7scevz #ItComesNaturallyToUs #TakingResponsibility #Sustainability #ESG

STADA is growing Europe’s number-one scalp health brand even further! With the upcoming launch of two new products, Nizoral Care Daily Conditioner and Nizoral Care Dry & Sensitive Shampoo, we’ve put consumers and science at the forefront. What excites Senior International Category Manager, Phoebe Buckley, most is the role these products will help play in strengthening the Nizoral brand through innovative additions that meet people's needs and desires. In this way, Nizoral serves as a comprehensive expert for good scalp health. Through our series of new product launches in Consumer Healthcare, we are opening up our innovative world to you! #STADAHeroBrand #NizoralCare #Nizoral #ScalpHealth #CaringForPeoplesHealth